Trials / Completed
CompletedNCT00002304
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 13 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To compare the safety, tolerance, and effectiveness of fluconazole and ketoconazole in the treatment of candidal esophagitis in immunocompromised patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketoconazole | |
| DRUG | Fluconazole |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
42 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00002304. Inclusion in this directory is not an endorsement.